Synthesis of novel cationic cardiolipin analogues for the optimal delivery of therapeutic agents

Tetrahedron Letters

Volumn 45, Issue 13, 2004, Pages 2743-2746

  Kasireddy, Krishnudu ^a   Ahmad, Moghis U ^a   Ali, Shoukath M ^a   Ahmad, Imran ^a  

^a NeoPharm Inc   (United States)

Author keywords

Cationic cardiolipin; Drug delivery; Gene transfer; Lipid based formulations

Indexed keywords

AMMONIUM DERIVATIVE; CARDIOLIPIN; GLYCEROL;

ARTICLE; CHIRALITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; GENE DELIVERY SYSTEM; MOLECULE; QUATERNARY;

EID: 1542328791     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2004.02.044     Document Type: Article

References (30)

1. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.S., Wenx M., Northrop J.P., Ringgold G.M., Danielsen H. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
2. Frederic M., Scherman D., Byk G. Tetrahedron Lett. 41:2000;675-679.
3. Ren T., Zhang G., Liu F., Liu D. Bioorg. Med. Chem. Lett. 10:2000;891-894.
4. Bessodes M., Dubertret C., Jaslin G., Scherman D. Bioorg. Med. Chem. Lett. 10:2000;1393-1395.
5. Obika S., Yu W., Shimoyama A., Ureda T., Miyashita K., Doli T., Imanishi T. Bioorg. Med. Chem. 9:2001;245-254.
6. Kim J.-M., Thompson D.H. Sur. Sci. Ser. 100:2001;145-154.
7. Banerjee R., Mahidhar Y.V., Chaudhuri A., Gopal V., Rao N.M. J. Med. Chem. 44:2001;4176-4185.
8. Jacopin C., Egron M.-J., Scherman D., Herscovici J. Bioorg. Med. Chem. Lett. 12:2002;1447-1450.
9. Ewert K., Ahmad E., Evans H., Schmidt H.-W., Safinya C.R. J. Med. Chem. 45:2002;5023-5029.
10. Nagasaki T., Taniguchi A., Tamagaki S. Bioconjugate Chem. 14:2003;513-516.
11. Llies M.A., Seitz W.A., Caproiu M.T., Miron T., Wentz M., Garfield R.E., Balaban A.T. Eur. J. Org. Chem. 14:2003;2645-2655.
12. Miller A.D. Angew. Chem., Int. Ed. Engl. 37:1998;1768-1785.
13. Chaudhuri A. Curr. Med. Chem. 2003;1185-1315.
14. Felgner P.L. Adv. Drug Delivery Rev. 5:1990;167-187.
15. Weiss B., Nitachko H., Wright R., Schlessinger S. J. Virol. 63:1989;5310-5318.
16. Malone R.W., Felgner P.L., Veras L.M. Proc. Natl. Acad. Sci. USA. 86:1989;6077-6081.
17. Chiang M.Y., Chan H., Zounes M.A., Freier S.M., Lime W.F., Bennett C.F. J. Biol. Chem. 255:1991;18162-18171.
18. Bennett C.F., Chiang M.Y., Chan H., Shoemaker J.E., Mirabelli C.K. Mol. Pharmacol. 41:1992;1023-1033.
19. Debs R.J., Freedman L.P., Edmunds S., Geensler K.L., Durgunes N., Yamamoto K.R. J. Biol. Chem. 265:1990;10189-10192.
20. Walker C. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7915-7919.
21. Felgner, P. L.; Fe, R. S.; Kumar, R.; Basava, C.; Border, R. C.; Felgner, H.; Yu, J. U.S. Patent No 5,264, 618, 1993.
22. Felgner, P. L.; Fe, R. S.; Kumar, R.; Basava, C.; Border, R. C.; Felgner, H.; Yu, J. U.S. Patent No 5,459,127, 1995.
23. Ioannou P., Golding B.T. Prog. Lipid Res. 17:1979;279-318.
24. Thompson D.A., Ferguson-Miller S. Biochemistry. 22:1983;3178-3187.
25. Bhattacharya S., De S., George S.K. Chem. Commun. 1997;2287-2288.
26. Wheeler, C.J. International Patent No WO 00/73263 A1, 2000.
27. Gaucheron J., Wong T., Wong K.F., Maurer N., Cullis P.R. Bioconjugate Chem. 13:2002;671-675.
28. Song Y.K., Liu F., Chu S., Liu D. Human Gene Therapy. 8:1997;1585-1594.
29. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.J. J. Biol. Chem. 269:1994;2550-2561.
30. Wheeler C.J., Sukhu L., Yang G., Tsai Y., Bustamente C., Felgner P., Norman J., Manthorpe M. Biochim. Biophys. Acta. 1280:1996;1-11.